New York · Nonprofit
ACTION TO CURE KIDNEY CANCER
ACTION TO CURE KIDNEY CANCER (New York) receives grants from 4 organizations whose IRS filings report $28,407 to it, the largest being NETWORK FOR GOOD ($25,790). 3 of them have funded it in more than one year, and 94% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- Revenue FY2025
- $0
- Funders on record
- 4
- Grants received
- $28k
- Net assets
- $93k
What Action to Cure Kidney Cancer does
Mission
Ackc was founded in order to educate the kidney cancer patients, caregivers and the general public about the disease; increase federal funding for cancer research; give modest grants to promising young investigators; publicize the causes and preventions of kidney cancer; negotiate with drug companies with respect to testing their products in kidney cancer patients.ackc mostly funds grants whose research big pharma does not find profitable and, over the years, we've issued grants in the amount of $400,000 to kidney cancer investigators. We concentrate on raising the awareness of causes such as pfas chemicals,and promote early detection and lifestyle changes since when kidney cancer is discovered at an early stage, the survival potential is higher.finally, we lobby congress to appropriate research money for kidney cancer. In 2006, were successful in having congress include kidney cancer in the department of defense's peer review cancer research
As stated on its FY2025 Form 990-EZ.
Program
Kidney cancer research
$0 spent
The program described on its FY2025 Form 990-EZ. Program spending in total: $0.
The organization over time
Each line starts at 100 in 2022, so what you read is the shape rather than the size: 150 means half as much again as 2022, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2024 to 2025, from $98k to $95k (−3%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
100% of ACTION TO CURE KIDNEY CANCER’s revenue is contributions — more reliant on donations than three-quarters of its peers (100% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 2 of the last 3 reported years ran a deficit.
Who funds it, year by year
2018 → 2023: the base held at 1 funder, grant income fell $11k → $168.
2 of 4 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 94% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of ACTION TO CURE KIDNEY CANCER’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
ACTION TO CURE KIDNEY CANCER leans on a few funders — its largest provides 91% of grant income and the top three 100%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
94% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund ACTION TO CURE KIDNEY CANCER.
Largest funder’s share by year: 2018 100% · 2019 100% · 2020 87% · 2021 62% · 2022 100% · 2023 100% — broadly stable.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
94% of ACTION TO CURE KIDNEY CANCER's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $2k that is directly attributable, 99% of it comes from New York funders.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $27k arriving through sponsors registered in 2 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
ACTION TO CURE KIDNEY CANCER's revenue fell 100% between 2022 and 2025.
this organization peer median middle 50% of peers· 6,360 health nonprofits under $100k, FY2025
Organizations like ACTION TO CURE KIDNEY CANCER
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In New York
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Public support
73%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 1 state
Screen this organization
A dated, signed PDF of the compliance screen for ACTION TO CURE KIDNEY CANCER: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds ACTION TO CURE KIDNEY CANCER?
- ACTION TO CURE KIDNEY CANCER (New York) receives grants from 4 organizations whose IRS filings report $28,407 to it, the largest being NETWORK FOR GOOD ($25,790). 3 of them have funded it in more than one year, and 94% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- How many funders does ACTION TO CURE KIDNEY CANCER have?
- IRS filings report 4 organizations giving $28,407 in grants to ACTION TO CURE KIDNEY CANCER, 3 of which have funded it in more than one year.
- Who is the largest funder of ACTION TO CURE KIDNEY CANCER?
- NETWORK FOR GOOD is the largest funder on record, with $25,790 in grants. The full list of funders is on this page.
- How can an organization like ACTION TO CURE KIDNEY CANCER find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in New York. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds Action to Cure Kidney Cancer →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2022–2025), and the filings of 4 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing